In the early steps of visual signal transduction, light-activated rhodopsin (R*) catalyzes GDP/GTP exchange in the heterotrimeric G protein (Gabc) transducin. We recently reported that the catalytic interaction involves two sequential steps. An initial docking between R* and Gbc leads to conformational changes which make the C-terminus of Ga (CTa) available for binding to R*. Binding of CTa by R* then triggers GDP/GTP exchange in the Ga subunit. To further study this two-step mechanism, we investigated different single amino acid substitutions within CTa and discuss the effects of high affinity mutations on nucleotide exchange catalysis.
Introduction
In numerous signalling pathways, heterotrimeric guanine nucleotide binding proteins (G proteins, Gabc) transduce extracellular signals sensed by transmembrane G protein-coupled receptors (GPCRs) to intracellular effector proteins (Cabrera-Vera et al., 2003) . A prototypical GPCR 2 is rhodopsin, the visual pigment of rod photoreceptor cells, which is responsible for vision under dim light conditions. In its dark adapted state, the chromophore 11-cis retinal is covalently bound as an inverse agonist and keeps the receptor inactive. Upon photon absorption, 11-cis ! all-trans retinal isomerization induces conformational changes in the protein moiety and starts formation of a series of photointermediates (Ernst & Bartl, 2002) . In milliseconds, an equilibrium between the two photoproducts metarhodopsin I (MI) and metarhodopsin II (MII) is reached. The G protein binds to MII, which is known as the active rhodopsin conformation (R*) capable of catalyzing GDP/GTP exchange in the retinal G protein transducin (Gt) (Okada, Ernst, Palczewski, & Hofmann, 2001) . Earlier studies have shown that two key binding sites on Gt, namely the C-terminal tail of Ga (CTat; ; Fig. 1A ) and the farnesylated C-terminal tail of Gc (CTc-far; Gc 1 (60-71)far), interact with R* and are involved in nucleotide exchange catalysis (Garcia, Onrust, Bell, Sakmar, & Bourne, 1995; Hamm et al., 1988; Herrmann et al., 2004; Kisselev, Ermolaeva, & Gautam, 1994; Kisselev, Meyer, Heck, Ernst, & Hofmann, 1999; Morizumi, Imai, & Shichida, 2003) . Like Gt, peptides corresponding to CTat and CTc-far are capable of binding to MII (Bartl, Ritter, & Hofmann, 2000; Kisselev et al., 1999) . Transferred NOESY NMR experiments showed that these peptides are disordered in solution. Upon binding to R*, CTat-derived peptides adopt a helical conformation with a helixterminating C-capping motif (as modelled in Fig. 1 ; Brabazon, Abdulaev, Marino, & Ridge, 2003; Kisselev et al., 1998; Koenig et al., 2002) . Furthermore, CTat-derived peptides containing multiple substitutions are known to possess increased affinity for R*. Analysis of the peptide sequences suggests that removal of the positive charge at the N-terminus of the peptide and at Lys 341 (Gat numbering) increases the affinity for R* (Aris et al., 2001; Herrmann et al., 2004; Martin, Rens-Domiano, Schatz, & Hamm, 1996) .
Recently, we proposed a model in which the G protein interacts with R* according to a sequential two step mechanism (Herrmann et al., 2004) . CTa is not available for interaction with R* in Gabc before an initial docking step between R* and the farnesylated Gbc dimer has occurred. A mutant G protein containing the high affinity K341L substitution (Gat numbering) in CTa showed an increased rate of GDP release and accelerated GTP uptake, supporting a direct involvement of CTa in the nucleotide exchange reaction.
In the present work, we characterize the effect of different amino acid substitutions at CTa's key position Lys 341 . We studied the R* affinity of mutant G proteins, synthetic CTa derived peptides and fusion proteins with CTa peptides. Analysis of binding data, probing the reactivity of a Cys residue in CTa peptides, and NMR studies allowed insights into a complex interplay between rhodopsin and the C-terminal region of transducin.
Materials and methods

Peptide synthesis
Peptide synthesis and purification were as described previously (Ernst et al., 2000b) . Purified and lyophilized peptides were dissolved in water and the pH was adjusted with 1 M NaOH up to pH 5-6. Sequences of peptides were derived from the C-terminus of bovine Gat. Amino acid sequences of the peptides were as in Fig. 1A . Unless otherwise mentioned, the carboxyl and amino termini of the peptides were unmodified. . Key binding sites for the active receptor are the C-terminus of Ga (CTa) and the farnesylated C-terminus of Gc (CTc), which were modelled according to NMR data (Kisselev & Downs, 2003; Kisselev et al., 1998) (both shown in orange, myristoylation at the Ga N-terminus is shown in grey). Amino acid sequences correspond to the C-terminal tail of Gat (CTat: residues 340-350), Gai1 (CTai: residues 344-354) or are modified from the CTat sequence. The CTa sequences were studied either as synthetic peptides, C-terminal MBP fusion proteins or as Cterminal sequence as part of Ga subunits. (B) MII is formed due to flash activation and stabilized in a concentration dependent manner by the peptide CTaL (pH 8.0, 4°C, 10 lM rhodopsin in ROS membranes, 11.5% of rhodopsin is flash activated, flash symbol indicates time of activation, peptide concentration as indicated). The amount of peptide-induced MII ('extra-MII') is the difference between the maximal DAbs values obtained with and without peptide. (C) The relative amount of peptide induced 'extra-MII' is plotted against the peptide concentration and fitted hyperbolically considering substrate depletion (for fit equation see Appendix A). Curves are normalized to the saturation level. Error bars are omitted for clarity. Data points are averages of three independent determinations. Derived dissociation constants are given in Table 1 . (For interpretation of the references in color in this figure legend, the reader is referred to the web version of this article.)
Membrane and transducin preparation
Bovine eyes were obtained from a local slaughter house. Rod outer segments (ROS) and rhodopsin membranes were prepared as described previously (Herrmann et al., 2004) . Gabc was purified and separated into Ga and Gbc subunits by chromatography on a cibacron blue column (HiTrap Blue, GE Healthcare Life Sciences) as described (Heck & Hofmann, 2001 ).
Cloning, expression, and purification of Ga subunits
Nonmyristoylated Ga subunits were expressed and purified from E. coli as described (Herrmann et al., 2004) . Experiments were performed with Gai1 which in combination with the Gb 1 c 1 isoform couples to rhodopsin as well as transducin (Gat/Gb 1 c 1 ) (Herrmann et al., 2004) . The plasmid pGiL harbouring the rat Gai1 coding sequence with an internal His 6 -tag was used for construction of Gai1 mutants (Herrmann et al., 2004) . pGiL was partially digested with AatII and HindIII and ligated with synthetic DNA duplexes encoding the last 14 C-terminal amino acids of native Gat or Gat containing the substitutions K341L or K341V, respectively.
Cloning, expression and purification of MBP fusion proteins
Cloning, expression and purification of the maltose binding protein (MBP) fusion proteins containing at the MBP C-terminus a Gly-Gly linker and 11 amino acids derived from the Gat C-terminus was as described previously (Herrmann et al., 2004) .
'Extra-MII' assay
The amount of 'extra-MII' (absorption maximum at k = 380 nm) was recorded by time-resolved UV/visible spectroscopy as described previously (Ernst, Bieri, Vogel, & Hofmann, 2000a) . Recorded traces represent the time dependency of absorption differences (A 380 -A 417 ; the isosbestic point between MI and MII is at 417 nm) from samples containing 10 lM rhodopsin in ROS membranes. Measurements were performed at pH 8.0 and 4°C. Cuvette path length was 2 mm. 11.5% of rhodopsin was flash-activated by 500 ± 20 nm light.
Fluorescence spectroscopy
G protein activation was monitored by relative changes in fluorescence emission at k = 340 nm (excitation at k = 300 nm). Samples containing rhodopsin (50 nM) in ROS membranes were illuminated with green light (k > 495 nm, 10 s) and the reaction was started by addition of GTPcS (5 lM final concentration) at 20°C and constant stirring (Ernst et al., 2000a) .
Near-infrared kinetic light scattering
Changes in light-scattering intensities were measured as described previously (Herrmann et al., 2004) . Measurements were performed in 10 mmpath cuvettes at pH 7.5, 23 ± 1°C and with 3 lM rhodopsin in ROS membranes. 32% of rhodopsin were activated using flashes of green light (k = 500 ± 20 nm). 1 H NMR spectra were recorded at various temperatures on a Bruker AVANCE DMX 600 NMR spectrometer locked to the deuterium resonance of the solvent. Samples of CTat and CTaL peptides (Fig. 1A) O, pH 7.5) and NMR spectra were recorded of both under identical conditions. Standard analysis of these data afforded the unambiguous sequential signal assignments in all cases. The cross peaks in the ROESY spectra taken at 285 K of the 90% aqueous phosphate buffer: 10% D 2 O solution at pH 7.5 containing 14 mM DTT of both peptides (7 mM) were integrated and calibrated against the peak of the asparagine side-chain amide group.
Nuclear magnetic resonance spectroscopy
Determination of the reaction rate between peptides and 4-PDS
The investigation of the chemical reactivity of sulfhydryl groups of CTa peptides was essentially performed as described (Cai, Langen, Hubbell, & Khorana, 1997; Klein-Seetharaman et al., 1999) . 4,4 0 -Dithiodipyridine (4-PDS) in MES buffer (20 mM Mes, 130 mM NaCl, and 1 mM MgCl 2 , pH 6.0) was added to peptide in Mes buffer such that the final concentrations were 2.5 mM 4-PDS and 45 lM peptide. The reaction at 20°C was followed by monitoring the time course of absorption change at k = 323 nm due to the formation of 4-thiopyridone (4-TP), using a Cary 50 UV/visible spectrophotometer (Varian). The cuvette path length was 10 mm.
Results
CTat-derived peptides with substitution of Lys
341 by hydrophobic residues have increased affinity for R* We explored how single amino acid substitutions at position 341 (Gat numbering) can increase the affinity of CTa for R*. By employing the 'extra-MII' assay (Emeis, Kü hn, Reichert, & Hofmann, 1982) , we determined affinities of CTat-derived synthetic peptides (Fig. 1A , Table 1 ). This assay is based on the depletion of the MI photoproduct and makes use of the fact that peptides, which stabilize the active MII conformation (k max = 380 nm), do this at the expense of the tautomeric MI photoproduct (k max = 480 nm). This increase of absorption caused by MII formation can be measured by UV/visible spectroscopy after flash activation of rhodopsin (Fig. 1B) .
All investigated CTa peptides stabilized MII in a concentration dependent manner. This is presented for CTaL (containing the K341L substitution) in Fig. 1B , showing eight superimposed time resolved 'extra-MII' measurements in the presence of increasing concentrations of CTaL peptide (0-100 lM). Amplitudes of absorption traces corrected for the amplitude of the reference trace (without peptide) define the amount of MII stabilized by added peptide ('extra-MII'). The amount of 'extra-MII' was plotted against the corresponding peptide concentration of the different peptides investigated (Fig. 1C) . Hyperbolically fitting of the data points yielded an EC 50 value of 3.9 lM in the case of CTaL. This corresponds to a dissociation constant (K D ) of 0.39 lM for the MIIAEpeptide complex, taking into account the MI/MII pre-equilibrium under the experimental conditions of the 'extra-MII' assay (approx. 90% MI and 10% MII, see Parkes & Liebman, 1984) . The same experiment was performed with peptides CTaI, CTaV, CTaF, CTaE, CTaS, CTaA (amino acid substitutions K341I, K341V, K341F, K341E, K341S and K341A, respectively), the native CTat peptide, N-terminal acetylated CTat peptide (Ac-CTat), and the CTai peptide (which corresponds to the CTat E342N substitution). The derived dissociation constants are given in Table 1 Table  1 ). The substitutions K341E, K341S and K341A just slightly increased the peptide affinities (K D values are 16.8, 42.6 and 28.0 lM, respectively, Table 1 ).
Next, we determined the affinities of the more hydrophobic CTaL and CTaF by a second approach. The CTaF peptide was expressed as fusion protein with maltose binding protein (MBP), yielding ''mass-tagged'' peptides. Binding of the MBP-CTaF fusion protein to R* was investigated by kinetic light scattering (Fig. 2) , a real time monitor for rhodopsin/G protein interaction (Heck, Pulvermü ller, & Hofmann, 2000; Herrmann et al., 2004) . Synthetic peptides without a ''mass-tag'' are too small to yield signals in the light scattering assay (Herrmann et al., 2004) . The complex formation between R* and its binding partner is reflected by an increase in the relative intensity of scattered light (DI/I, binding signal) after activation of rhodopsin by a green light flash. Similar to the isolated peptide in the 'extra-MII' assay, MBP-CTaF binds to R* in a concentration dependent manner. Analysis of the amplitudes of the binding traces yielded an EC 50 value (concentration of half maximal saturation) of 1.6 lM (K D of 1.3 lM, see Appendix A), which is similar to the dissociation constant obtained by the 'extra-MII' assay (2.17 lM, Table 1 ).
The same light scattering experiment was performed with MBP-CTaL, yielding a K D of 0.2 lM (data not shown). This is in good agreement with the dissociation constant obtained by the 'extra-MII' assay for the corresponding synthetic peptide CTaL (0.39 lM, Table 1 ). A similar conformity was found for the CTat-derived peptide VLEDLKSCGLF that showed high affinity for R* (K D = 0.36 lM as determined by the 'extra-MII' assay; data not shown), in agreement with earlier determinations (Aris et al., 2001; Herrmann et al., 2004; Kisselev et al., 1999) .
The K341L substitution in CTa affects the affinity of the G protein only marginally
The K341L substitution greatly enhances the affinity of the CTa peptide for R* (Fig. 1B and C) . Therefore, we next characterized the effect of this substitution on G protein binding to R*. We expressed mutants of the nonmyristoylated Gai1 subunits harbouring the CTat or CTaL sequence in Escherichia coli (subunits are termed Ga-CTat or Ga-CTaL, respectively; Ga-CTai represents Gai1). For these studies Gai1 was chosen, because it belongs to the same Ga subfamily as Gt, couples with Gbc to rhodopsin and can be expressed in high quantities in E. coli (Herrmann et al., 2004) .
The R*-catalyzed GDP/GTP exchange in these G proteins was measured by fluorescence spectroscopy. After illumination of the sample and addition of GTPcS, the uptake of GTPcS is accompanied by an increase of the relative fluorescence emission caused by the conformational change in Ga. The data show that all three G proteins expressed were functional. The G protein containing the K341L substitution showed a slightly faster GTPcS uptake kinetics compared to Ga-CTai (Fig. 3) . This is in agreement with our previous results obtained by kinetic light scattering (Herrmann et al., 2004) . The rate of GTPcS uptake by the G proteins containing Ga-CTat and GaCTaL is very similar. The slower GTPcS uptake of GaCTai can therefore be attributed to the Glu/Gln exchange at position 342.
We determined the R* affinities of the prepared G proteins by 'extra-MII' measurements. Fig. 4 shows seven superimposed 'extra-MII' traces in the presence of various concentrations of Ga-CTat/Gbc (Fig. 4A, 0-8 lM) , GaCTai/Gbc (Fig. 4B, 0-8 lM) and Ga-CTaL/Gbc (Fig. 4C, 0-7 lM) , respectively. Surprisingly, stabilization of MII was observed for all three Ga/Gbc combinations in a similar manner. By hyperbolically fitting of the signal amplitudes we obtained very similar EC 50 values for all three G proteins. The values were 2.5 lM (Ga-CTat/ Gbc), 2.8 lM (Ga-CTaL/Gbc) and 2.0 lM (Ga-CTai/ Gbc), respectively.
These experiments indicate similar R* affinities of the three G proteins. Next, we used the kinetic light scattering assay to verify these results under more physiological conditions (23°C and pH 7.4 compared to 4°C and pH 8.0 in the 'extra-MII' assay). In this assay, the light-induced binding of G proteins from solution to rhodopsin containing disk membranes is directly monitored as an increase of the intensity of scattered light (Heck et al., 2000; Herrmann et al., 2004) . In the dark, the three investigated G proteins were quantitatively located in solution due to the lack of Ga myristoylation (Herrmann et al., 2004) . In this sample, the maximum level of intensity of scattered light is directly proportional to the amount of the formed R*AEG protein complex after illumination (Heck et al., 2000) . Fig. 5 shows Fig. 3 . Receptor catalyzed GTPcS uptake by G proteins containing the Ga-CTat, Ga-CTaL or Ga-CTai subunit. Light-activated rhodopsin (50 nM) catalyzed GTPcS uptake by 0.6 lM Ga-CTat, Ga-CTaL or GaCTai, respectively, in combination with 0.5 lM Gbc. The reaction was monitored by measuring the increase of fluorescence emission and started by addition of 5 lM GTPcS (time of GTPcS addition is indicated by an arrow). binding signals of the three different G proteins at the concentrations indicated. Affinities are evaluated as performed for the MBP-CTaF fusion protein (see Fig. 2 ). The EC 50 values for the R*AEG protein complexes were 0.72 lM (Ga-CTai/Gbc), 0.69 lM (Ga-CTat/Gbc) and 0.55 lM (Ga-CTaL/Gbc). Whereas the CTaL substitution increased the affinity of the CTat peptide by two orders of magnitude, the same substitution had almost no influence on the EC 50 value of the respective G protein for binding to the receptor.
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3.3. In Ga-CTaL and Ga-CTaV, CTa is accessible for binding to R* In the dark, neither Ga-CTat, Ga-CTai, Ga-CTaL nor Ga-CTaV bound to rhodopsin containing membranes. In contrast to Ga-CTat and Ga-CTai, the single amino acid substitution K341L in Ga-CTaL allowed this subunit to bind very slowly and independently of Gbc to R* in a concentration dependent manner ( Fig. 6 ; Herrmann et al., 2004) . No binding of Ga-CTaL was seen when competing CTaL peptide (50 lM) was added (data not shown). The same slow Gbc independent binding could be observed with the Ga-CTaV subunit (carrying the K341V substitu- tion, data not shown). The slow binding kinetics of GaCTaL and Ga-CTaV after illumination suggested that in these mutants the CTa binding site is available for interaction with R* and adopts a conformation that can be recognized by R*. The scheme in Fig. 6A suggests that CTa exists at least in two different conformational states, in an inactive, non-binding conformation, and in an active R*-specific conformation (CTa in and CTa a , respectively; equilibrium 1 in Fig. 6A ). The data set (Fig. 6B) was fitted according to the reaction scheme in Fig. 6A (fit is shown as dotted red line in Fig. 6B ). The rate constants are consistent with the notion that the adoption of the active, R* binding CTa a conformation is the rate limiting step (Table 2 ) which can explain the slow binding of Ga-CTaL to R*.
The reactivity of the sulfhydryl group in CTat-derived peptides is correlated to their affinity for R*
To further test the idea that CTa exists in different conformations (CTa in and CTa a ), we studied the reactivity of the sulfhydryl side chain of Cys 347 within CTatderived peptides (Fig. 7) . The NMR structure of a CTatderived peptide in the R*-bound conformation shows that the side chain of residue 347 is shielded by Phe 350 , Leu 349 and Leu 344 (PDB code 1LVZ; Koenig et al., 2002) . Therefore, the accessibility of the Cys 347 sulfhydryl side chain may be reduced in the proposed active CTa a conformation. The reaction scheme in Fig. 7A assumes that only the inactive CTa in conformation reacts with 4-PDS, whereas the reactivity of the Cys sulfhydryl in the active CTa a conformation is negligible. We tested this by using the sulfhydryl specific reagent 4,4 0 -dithiodipyridine (4-PDS) to determine the reactivity of the Cys 347 side chain. The rate of thiopyridone (4-TP) formation by this reaction was measured using UV/visible spectroscopy ( Fig. 7B) with the peptides CTat, CTaL and the sulfhydryl lacking peptide CTat-S containing the C347S substitution. As expected, no reaction was observed with the control peptide CTat-S. The peptide CTaL reacted slower with 4-PDS than the native peptide CTat. The data points were fitted by a numerical least-square fitting procedure on the basis of the reaction scheme in Fig. 7A (see Appendix A). The rate constants of the reaction scheme and calculated equilibrium constants for the equilibrium between CTa in and CTa a are given in Table 3 . The equilibrium constant determined for peptides CTat and CTaL is 0.041 and 1.642, respectively. Hence, the equilibrium between CTa in and CTa a is shifted by a factor of 40 to the side of CTa a due to the K341L substitution.
The peptides CTat and CTaL show structural differences
The reaction scheme presented in Fig. 6A assumes that, before binding to R*, CTa exists in equilibrium between two different conformational states. Since this equilibrium is affected by the peptide sequence, we expected that CTat-derived peptides of different affinities show structural differences in solution. We performed NMR experiments under different solvent conditions with the aim of measuring structural differences between the CTat and CTaL peptides. Both peptides produced well resolved 1 H NMR spectra under all solvent conditions used. Peptides showed a tendency to form dimers through disulfide bridge formation that was particularly prominent at the highest pH (7.5 in aqueous phosphate buffer) and could be reversed by the addition of DTT. At low pH values the samples were stable Table 2 Rate constants obtained by fitting the light scattering data in Fig. 6 k 1,on (s À1 10
0.1 246.6 0.0004 386.0 5.8 0.02 50
is defined by the product (1/K 1 ) K D2 ; i.e., the ratio (k 1,off. k 2,off )/(k 1,on. k 2,on ). 0 -dithiodipyridine (4-PDS) reacts with the sulfhydryl group of the peptide's Cys (Cys 347 in Gat, Fig. 1A ) when the peptide adopts the inactive CTa in conformations. For the active CTa a conformations, it is assumed that the sulfhydryl group is less accessible for the reaction. Therefore, 4-PDS reactivity of peptides in the CTa a conformations is not considered. (B) Time courses of the modification of CTa peptides with 4-PDS are shown for the peptides CTat, CTaL and CTat-S (CTat-S lacks a sulfhydryl group due to the C347S substitution). The absorption change at 323 nm (k max of thiopyridone) is plotted against time. The reaction was started by the addition of dissolved 4-PDS to the peptide solution at t = 0 min. Numerical least square fits of the data points yielded the corresponding rate constants of the reaction scheme in (A) (summarized in Table 3 ). The fitted curves are plotted as grey lines.
without DTT and complete data sets could be recorded. However, dimer formation could be induced even at pH 3 by bubbling air through the solution.
Initially 50% trifluoroethanol-d 2 : 50% H 2 O at pH ca. 3 was chosen as solvent assuming that this solvent stabilizes peptide structures and would therefore allow any major structural differences between the peptides to be observed. Significantly no differences were observed in the cross peaks in the 2D NOESY and ROESY spectra indicating both peptides showed the same global behaviour in this solvent system (data not shown). Significantly both peptides showed NH-NH (i, i + 1) ROESY and NOESY responses for the C-terminal region between K-6 and L-10 (11mer peptide numbering; corresponding to Lys 345 and Leu
349
(Gat numbering)). This suggests both peptides have preferred conformational propensities in this region. The absence of any medium range NOEs indicated the transient nature of these structures and implies that both peptides showed the same behaviour under these hydrophobic conditions. In a second set of experiments we used conditions that corresponded as close as possible to those of the biochemical studies described above, namely 90% aqueous phosphate buffer: 10% D 2 O, pH 7.5. Under these conditions the peptides showed subtle spectral differences (data not shown). At room temperature exchange broadening precludes the observation of most of the amide signals apart from the C-terminal residues indicating again that only these residues are in a structured section of the peptides. Upon lowering the temperature the amide exchange rate decreases causing the signals to sharpen and increase in intensity. Comparison of the spectra indicates that CTaL tends to show sharper signals at all temperatures than CTat suggesting a more structured state. As expected, there were few NH-NH (i, i + 1) NOEs in the 2D ROESY spectra recorded at 285 K and these were less intense than those for the trifluoroethanol spectra, indicating the presence of a structural propensity for the C-terminal region. Importantly, there were intensity differences between the two peptides for the NH-NH (i, i + 1) NOEs, aH-NH (i, i + 2) NOEs, and the internal NOEs (aH-dH and bH-dHs) of the terminal Phe residue which indicate the partial ordered nature of this residue (Koenig et al., 2002) . Internal calibration of these NOEs in the 2D ROESY spectra against the protons of the Asn side-chain amide group of each peptide allowed subtle differences between the peptides to be monitored (Table 4) . Thus in all cases the relative intensity of the relevant NOEs were more intense for CTaL than for CTat implying a more structured ensemble of likely interconverting conformations in the former peptide. Our data are compatible, although somewhat different, to those observed previously by Brabazon and co-workers (Brabazon et al., 2003) . They observed for the free peptides in solution a distinct differential NOESY response between CTat (IKENLKDCGLF) and a related high affinity peptide (VLEDLKSCGLF), such that only the latter exhibited the NH-NH (i, i + 1) signals.
Discussion
In our preceding work we described a two step sequential fit mechanism for formation of the nucleotide-free R*AEG protein complex. This mechanism includes initial docking between Gbc and R* which is necessary to make the C-terminal binding site of Ga, CTa, available for R* (Herrmann et al., 2004) . Further, the main stability of the nucleotide-free R*AEG protein complex arises from the interaction between CTa and R*. In the present work, we focused on CTa and examined the effect of mutations within CTa on R*/G protein interaction.
We studied CTa as an isolated binding site (i.e. as synthetic peptide, Fig. 1 , or ''MBP-tagged'' peptide, Fig. 2 ) by utilizing two different biophysical monitors, UV/visible spectroscopy (see Fig. 1 ) and kinetic light scattering (Fig. 2) . Lys 341 appeared to be crucial for the CTa affinity. This is in accordance with other reports that describe the effect on affinity of multiple-site-substitutions within CTa (Aris et al., 2001; Kisselev et al., 1998; Martin et al., 1996) . We found that just a single amino acid substitution Values are averages of at least three independent measurements. Errors are given as the standard error of the means (SEM). No errors are obtained when parameters were fixed during the fitting session. K 1 = k 1,on /k 1,off . is sufficient to increase the affinity of CTa for R*. The largest gain of affinity could be achieved by not only removing the positive charge of Lys 341 , but by substitution with hydrophobic residues. The affinity increase was dependent on the size of the side-chain, and was two orders of magnitude for Leu or Ile and one order of magnitude for Val or Phe (Table 1 ). In addition, UV/visible spectroscopy ('extra-MII' assay) showed that removal of the negative charge of the adjacent Glu 342 by substitution with Asn had little effect on the affinity (Fig. 1C and Table 1 ).
An explanation for the increased affinity of CTa peptides with hydrophobic substitutions of Lys 341 may be found in the peptide conformation. The structure of CTa in the R*-bound state was determined by transferred NOESY NMR studies on synthetic peptides (Kisselev et al., 1998; Koenig et al., 2002) . According to these experiments R*-bound CTa adopts a near-ideal a-helix that is terminated by a C-capping motif of an a L type with Gly 348 in the centre of the reverse turn (as modelled in Fig. 1A ). This leads to a clustering of hydrophobic side chains, i.e. Phe 350 , Leu 349 and Leu 344 , residues which are highly conserved among G proteins. A CTat-derived peptide with the substitution of Leu 349 by the shorter Ala residue (IKENLKDCGAF) fails to stabilize MII even at high concentrations (Morizumi et al., 2003) . Gly 348 appears to be invariant for CTa binding to R* (Garcia et al., 1995) . Phe 350 within this hydrophobic cluster is in proximity to the positively charged Lys 341 side-chain, suggesting that substitution of Lys 341 by a hydrophobic residue may have an effect on the propensity of C-capping formation. Our NMR experiments show that, in the absence of R*, both peptides displayed no overall helical or other stable longrange structures even under hydrophobic conditions which are known to stabilize secondary structures in peptides. However, the C-terminal region of the CTa peptides showed an increased tendency for the formation of partially structured C-capping-like conformations. This is consistent with the reaction scheme presented in Fig. 6A and Fig. 8 . In this scheme, the peptides exist in two main conformational states, an ensemble of disordered, inactive conformations CTa in , and a partially structured, but still fluctuating ensemble of conformations, i.e. conformers, with an increased propensity for the C-terminal C-capping-motif. This active CTa a ensemble enables interaction with R*, eventually leading to the R*AECTa b complex (see Fig. 8 ). On basis of the previous NOESY NMR data (Brabazon et al., 2003; Kisselev et al., 1998; Koenig et al., 2002) we assume that in the R*-bound state CTa b , formation of the final a-helix preceding the terminating C-capping motif is induced. Importantly, our NMR measurements indicate that the CTaL peptide is more structured than CTat in aqueous buffer at physiological pH (Table 4) . The high-affinity peptide CTaL exhibits a higher propensity for C-capping-like conformations in the C-terminal peptide region. This allows the interpretation that for CTaL, an increased fraction of active CTa a conformers exists compared to the native CTat peptide (see equilibrium 1 in Fig. 8A ). Furthermore, it is likely that the more hydrophobic Leu residue increases the affinity because it fits better into its binding pocket of R* (equilibrium 2 in Fig. 8A ). Therefore, in terms of the model in Fig. 8 , the observed dissociation constant of the R*AE peptide complex would be reduced due to the shift of the coupled equilibria.
Our assumption of CTa in and CTa a conformers is supported by the different reactivity of Cys 347 within the Ccapping region of CTat and CTaL peptides (Fig. 7) . The fact that the known structures of CTa peptides in the R*-bound conformation show two different orientations of the Cys 347 side-chain, namely either solvent exposed (PDB: 1AQG) or partially shielded from the solvent (PDB: 1LVZ), argues also for a variety of C-capping-like structures in the active CTa a conformers. Therefore, the sulfhydryl group of Cys 347 might be less accessible in the ensemble of CTa a conformers compared to inactive, fluctuating CTa in . With the experiments presented in Fig. 7 we tested the fraction of native CTat and high affinity CTaL peptide in the CTa in conformational state. Accordingly, we indeed found a lower Cys reactivity for the high affinity CTaL peptide (Table 3) which is consistent with an increased fraction of C-capping-like CTa a conformers with negligible Cys reactivity.
A further support for this model is provided by light scattering experiments in which the fraction of active CTa a conformers is directly probed by complex formation with R* (Fig. 6) . The K341L and K341V substitutions in nonmyristoylated Ga-subunits (Ga-CTaL and Ga-CTaV) enabled binding of Ga to R* in the absence of Gbc. In contrast, binding of Ga containing native Lys 341 could only occur in complex with Gbc. Again, the kinetic analysis of the binding data in Fig. 6 is consistent with the equilibrium between inactive and active CTa conformers.
In contrast to the CTaL peptide, the fraction of GaCTaL present in the CTa a conformation is low, which results in the low observed affinity of the isolated Ga-CTaL subunit (K D, app = 50 lM, Table 3 ). Therefore, it is likely that steric and/or conformational constraints exerted within the Ga subunit strongly affect the promotion of active CTa a conformers. In terms of this interpretation, the intrinsic tendency of the native C-terminus to form active CTa a would not be sufficient to overcome these constraints. Interestingly, the kinetic analysis yields a low dissociation constant for the second equilibrium step (equilibrium 2 in Fig. 6A ), reflecting the high affinity of the CTaL C-terminus towards its R* binding site (K d2 = 0.02 lM). The very slow binding of this mutated Ga-subunit can be explained by a rate limiting conformational transition towards active Ga conformers with subsequent binding to R*. It is interesting to note that the proposed equilibrium of inactive and active CTa conformations is in agreement with a study using cyclic CTa peptides that mimic an active, C-capping-like CTa a conformation. It was found that preorganization of an active conformation by cyclization led to an increased affinity for MII (Arimoto, Kisselev, Makara, & Marshall, 2001) .
It was previously predicted that C-terminal high affinity mutations within CTa would lead to a higher receptor affinity and a lower activation rate of the G protein (Martin et al., 1996) . Thus, we examined the effect of the C-terminal high affinity K341L mutation (CTaL) within the Gabc heterotrimer by applying the same biophysical techniques as for the peptide studies (see Figs. 4 and 5) . Surprisingly, in strong contrast to the behaviour of the peptide and MBP fusion protein, the K341L substitution did not significantly affect the affinity of mutated Gabc for R*. The three investigated G proteins (Ga-CTat, Ga-CTai and Ga-CTaL in complex with Gbc) showed almost identical affinities for R*, as demonstrated by binding to R* in the light scattering assay (see Fig. 5 ) and stabilization of MII ('extra-MII' assay, see Fig. 4 ). It cannot be completely excluded that the lack of the myristoyl group renders heterotrimeric G proteins containing the wild type or K341L mutant CTa to behave similar. However, our previous work indicated that CTa interacts with rhodopsin in a second binding step after initial docking of the hydrophobic farnesyl and/or myristoyl moiety to rhodopsin (Herrmann et al., 2004 , Herrmann, Heck, Henklein, & Ernst, 2006 . Interaction of heterotrimeric Gt with R* requires the presence of only one hydrophobic modification, i.e. farnesylation and myristoylation can replace each other in the docking process (Herrmann et al., 2004 (Herrmann et al., , 2006 . Thus the lack of the myristoyl moiety is unlikely to account for the similarity of wild type and the K341L mutant in binding to R*.
The proposal of inactive and active CTa conformers in context with our previously published sequential fit model (Herrmann et al., 2004 ) may give a further hint for the interpretation of the puzzling discrepancy between peptide and G protein affinities. The last seven amino acids of the Ga carboxyl terminus are not resolved in the available crystal structures of G protein heterotrimers. Furthermore, Lys 341 is oriented towards the solvent and not involved in intramolecular bonding (Lambright et al., 1996; Wall et al., 1995) . This suggests that the outermost part of the Ga C-terminal region adopts disordered, fluctuating CTa in conformations in the non-R*-bound G protein. Accordingly, the G protein's CTa is not available for R* before the initial binding step via Gbc has occurred and the N-terminal part of CTa is unleashed (Herrmann et al., 2004) . We suggest that this initial docking step serves to position CTa into the proximity of its binding site on R*. This diminishes the degrees of freedom of CTa in and facilitates the adoption of an active CTa a conformation (equilibrium 1 in Fig. 8B ). In the G protein, CTaL's increased tendency to form active CTa a is not crucial, since during the R*AEG protein interaction active CTa a conformers are favored compared to the free peptide. Once formed in the dynamic R*AEG protein complex, the C-capping like structures of unleashed CTa a can be recognized by R*. This induces the final fitting process with R* and results in CTa's a-helical conformation with helix-terminating C-capping (equilibrium2 in Fig. 8B ).
Further studies are necessary to prove this hypothesis and to address what conformational changes in the G protein are needed to make CTa available for R*. Although many investigations aimed to provide information about the CTa/R* interface (Acharya, Saad, & Karnik, 1997; Aris et al., 2001; Cai, Itoh, & Khorana, 2001; Ernst et al., 2000b; Garcia et al., 1995; Janz & Farrens, 2004; Martin et al., 1996; Natochin, Muradov, McEntaffer, & Artemyev, 2000; Onrust et al., 1997; Terakita, Yamashita, Nimbari, Kojima, & Shichida, 2002; Wang, Kim, Ablonczy, Crouch, & Knapp, 2004) , it is still unclear where CTa exactly binds. Likewise, the functional unit of active rhodopsin is not yet identified (see e.g. Chabre & le Maire, 2005; Park, Filipek, Wells, & Palczewski, 2004) . Our proposed mechanism is compatible with different conceivable scenarios, e.g. binding of Gt to an activated rhodopsin monomer; interaction between Gt and a rhodopsin dimer or even higher oligomer; or binding of Gt to an activated rhodopsin monomer with subsequent receptor dimerization or oligomerization (Herrmann et al., 2006) . Future investigations have to address which of these scenarios properly describes the rhodopsin/Gt interaction.
Furthermore, it remains to be studied how R* allows CTa to reach its final binding conformation and whether, for example, proton transfer reactions such as neutralization of Lys 341 are involved in the binding process. All these studies have to be done with the full length heterotrimer. Although Gat-derived peptides may give important information which can be obtained more readily, they are, however, incomplete mimics of the full length protein for gaining both structural and kinetic data as shown in this article.
